Healthcare & Life Sciences
Cura Therapeutics
United Statescuratherapeutics.com
Cura Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 2 tracked investors.
Activeseries-a
series-a
Stage
2
Investors
About Cura Therapeutics
Cura Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Cura Therapeutics develops multimodal immunotherapies, including its lead candidate CT101, designed to treat metastatic cancers and age-related diseases by activating immune responses, reducing tumor immunosuppression, and disrupting tumor blood supply.
Explore Cura Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.